Skip to main content

About
Awards
Events
Value Assessment
News
Donate
Blog
Apply

Improving public health by proactively investing in innovative research, education and value-driven health care

Home > Research > The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy

The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy

Meet Our Awardees
Sitemap
Contact Us
PhRMA

PhRMA Foundation

950 F Street, N.W.
Suite 300
Washington, DC 20004
(202) 572-7756